Oscar Health (NYSE:OSCR - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.28 by $0.34, Briefing.com reports. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The company had revenue of $2.14 billion during the quarter, compared to analyst estimates of $1.99 billion. During the same quarter in the previous year, the company posted ($0.18) earnings per share. Oscar Health's revenue was up 45.8% compared to the same quarter last year.
Oscar Health Price Performance
Shares of OSCR stock traded up $0.98 on Wednesday, hitting $20.75. 5,758,177 shares of the stock traded hands, compared to its average volume of 3,296,542. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.19 and a quick ratio of 1.19. Oscar Health has a 52 week low of $4.72 and a 52 week high of $20.76. The firm has a 50 day simple moving average of $15.41 and a two-hundred day simple moving average of $11.96. The firm has a market cap of $4.77 billion, a price-to-earnings ratio of -16.67 and a beta of 1.66.
Wall Street Analysts Forecast Growth
OSCR has been the subject of a number of recent research reports. Raymond James assumed coverage on Oscar Health in a research note on Friday, March 22nd. They set an "outperform" rating and a $20.00 price target for the company. TheStreet raised shares of Oscar Health from a "d" rating to a "c-" rating in a report on Wednesday, February 21st. Wells Fargo & Company lifted their price target on shares of Oscar Health from $12.00 to $20.00 and gave the stock an "overweight" rating in a research note on Thursday, February 15th. Finally, The Goldman Sachs Group upped their price objective on Oscar Health from $8.00 to $16.00 and gave the stock a "neutral" rating in a research note on Friday, February 9th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $13.50.
Check Out Our Latest Stock Analysis on OSCR
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.
Get This Free Report
